Amy Quinlan - 21 Jun 2024 Form 3 Insider Report for Vor Biopharma Inc. (VOR)

Role
Vice President of Finance
Signature
/s/ Katie Kazem, Attorney-in-Fact
Issuer symbol
VOR
Transactions as of
21 Jun 2024
Net transactions value
$0
Form type
3
Filing time
26 Jun 2024, 17:22:56 UTC
Next filing
04 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VOR Common Stock 55,812 21 Jun 2024 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VOR Employee Stock Option (right to buy) 21 Jun 2024 Common Stock 117,127 $1.90 Direct F4
holding VOR Employee Stock Option (right to buy) 21 Jun 2024 Common Stock 29,000 $8.63 Direct F5
holding VOR Employee Stock Option (Right to Buy) 21 Jun 2024 Common Stock 22,500 $5.55 Direct F6
holding VOR Employee Stock Option (Right to Buy) 21 Jun 2024 Common Stock 12,500 $2.41 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 15,000 shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs shall vest in full on September 1, 2024, subject to the Reporting Person's continued service as of each such date.
F2 Includes 7,735 shares underlying RSUs. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs shall vest in eleven quarterly installments beginning on August 6, 2024, subject to the Reporting Person's continued service as of each such date.
F3 Includes 17,579 shares underlying RSUs. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs shall vest in fifteen quarterly installments beginning on August 1, 2024, subject to the Reporting Person's continued service as of each such date.
F4 The original option award was for 122,127 shares. 25% of these options vested on August 28, 2021, and the remainder vest over the following three years in equal monthly installments, subject to the Reporting Person's continuous service through each such vesting date.
F5 These options vest over four years in equal monthly installments beginning March 1, 2022, subject to the Reporting Person's continuous service through each such vesting date.
F6 These options vest over four years in equal monthly installments beginning March 6, 2023, subject to the Reporting Person's continuous service through each such vesting date.
F7 These options vest over four years in equal monthly installments beginning March 1, 2024, subject to the Reporting Person's continuous service through each such vesting date.